Accordingly, nuclear localized Akt as been shown to enhance breast cancer stem-like cells through inactivation of cell cycle inhibitors p21 and p27 or through FoxO-Bim pathway [44, 45]. The gene discussed is BCL2L11; the disease is breast cancer.